KALV - KalVista Pharmaceticals GAAP EPS of -$0.75 beats by $0.26
2023-03-09 07:17:48 ET
- KalVista Pharmaceticals press release ( NASDAQ: KALV ): Q3 GAAP EPS of -$0.75 beats by $0.26 .
- Cash, cash equivalents and marketable securities were $171.7 million as of January 31, 2023, compared to $166.2 million as of April 30, 2022.
For further details see:
KalVista Pharmaceticals GAAP EPS of -$0.75 beats by $0.26